Item 8.01 Other Events.
On December 23, 2008, Neurogen Corporation (the "Company") issued a press
release, attached hereto as Exhibit 99.1 and made part of this report,
announcing that it has entered into a definitive agreement to sell its C5a
patent estate and related assets to a major pharmaceutical company for $2.25
million. Also, on December 16th, 2008, Neurogen received the final payment on
the previously announced $3 million sale of its chemical library to a major
pharmaceutical company
Exhibits.
99.1 Press Release, dated December 23, 2008.
Add
NRGN to Portfolio
Set Alert
Email to a
Friend